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Relapse of bacterial infection is a major problem in the chemotherapy of chronic bronchitis (May, 1968) . Haemophilus influenzae, the important pathogen, is only moderately sensitive to antibacterial drugs, most of which penetrate into bronchial secretions poorly and probably cause the bacteria to be only partially suppressed. An antibiotic often used for the treatment of bronchial infection is ampicillin. Although it is bactericidal against H. influenzae in vitro, it is only occasionally able to prevent relapse of H. influenzae bronchial infections and even then it has to be given in large doses (May and Delves, 1965) . These authors consider this is due to the poor penetration of ampicillin through the blood-bronchial fluid barrier so that bactericidal levels for H. influenzae are not reached in respiratory tract secretions. Low levels of ampicillin have also been found in cerebrospinal fluid (Taber, Yow, and Nieberg, 1967) and aqueous humour (Goldman, Broughton, Javed, and Lauderdale, 1973) even when large parenteral doses are administered. These observations are in keeping with the physicochemical properties of ampicillin. It has an even stronger acidic group (pKa=2-52) than benzylpenicillin (pKa=2-72) (Rapson and Bird, 1963 ) so that at blood pH it would be virtually completely ionized and therefore would be expected to pass through lipoid membrane barriers poorly. Another possible factor which might result 'Present address: KRUF Institute of Renal Disease, Cardiff Royal Infirmary in low concentrations of ampicillin in bronchial secretions is an active transport mechanism which pumps the drug out of bronchial fluid. Such a mechanism has been demonstrated for the absorption of organic acids including penicillin from cerebrospinal fluid (Fishman, 1964) and from aqueous humour (Becker, 1960) and is similar to that in the renal proximal tubule.
These experiments were designed to determine whether active reabsorption of ampicillin from the lungs is a factor responsible for the low levels of the drug in sputum.
Evidence is presented in this paper suggesting that ampicillin is absorbed from the lungs by passive diffusion rather than by active transport.
SUBJECT AND METHODS
These studies were performed on a 28-year-old healthy male volunteer (J.L.M.). The subject had fasted overnight and before the intratracheal injection drank a pint of water to ensure that urine could be passed during the experiment.
INTRATRACHEAL INJECTION The subject was seated upright in a chair with the neck extended, and the skin overlying the cricothyroid membrane was infiltrated with 2% lignocaine. After a few minutes 2 ml of 2% lignocaine was injected into the trachea through the cricothyroid membrane. This was followed by vigorous coughing and resulted in numbing of the throat and some loss of voice. A few minutes later a further 2 ml of 2% lignocaine was injected into the trachea to test for abolition of the cough reflex. When this had occurred, 50 mg of ampicillin dissolved in 5 ml of sterile pyrogen-free water was injected into the trachea. Venous blood samples were taken after 20 and 40 minutes, 1, 11, 2, 21, 3, 31, and 4 hours and the plasma was separated. All urine passed 1, 1, 11, and 2 hours after the intratracheal dose was collected and the volume measured.
This procedure was repeated at weekly intervals using doses of 250 mg and 1,250 mg of ampicillin respectively.
The effect of probenecid on ampicillin absorption from the lungs was studied by giving ampicillin 250 mg together with probenecid 100 mg in 5 ml of water by intratracheal injection and taking venous blood samples as before.
BRONCHIAL SLICE TECHNIQUE Cross and Taggart's (1950) renal slice technique for the study of active transport of organic acids by the kidney was modified and used with bronchial slices. This method involved incubating slices of bronchus in Krebs-Ringer solution containing ampicillin and measuring its concentration in the tissue and culture medium after a period of incubation.
Human foetal bronchus was obtained from the Royal Marsden Hospital Organ Culture Bank, London.
Slices of bronchus less than 0 5 mm thick were cut with a razor, dried with blotting paper, and weighed. Bronchial slices weighing approximately 200 mg were divided into four aliquots. Each aliquot was placed on a piece of filter paper (2X3 cm) and floated on 5 ml of culture medium (Krebs-Ringer solution containing 20 jg/ml of ampicillin) in a plastic Petri dish as shown in Figure 1 . A stream of gas (95% 02 and 5 % C02) was passed into the culture medium beneath the filter paper by piercing the side of the Petri dish with a No. 1 needle. This stream of gas served to keep afloat the filter paper which tended to sink when wet, agitated and buffered the culture medium, and supplied oxygen to the slices. The bronchial slices were incubated at 37°C for 16 hours. After this period they were shown to be viable by the presence of active ciliary movement observed microscopically. Homogenization of the bronchial slices was performed with a glass tissue grinder, and samples of the supernatant together with samples of the culture medium were obtained.
All samples for ampicillin assay were stored at -20°C until analysed. Ampicillin was assayed in the As shown in the Table, the larger the intratracheal dose of ampicillin, the greater is the amount excreted in the urine. Ratios of the cumulative weights of ampicillin excreted in the urine after each of the three doses were as follows: cumulative weight of ampicillin excreted in the urine was 1: 5, which is the ratio of the doses. This is the ratio one would expect to find if ampicillin was absorbed from the lungs by passive diffusion.
Coughing following the 1,250 mg dose of ampicillin would tend to increase its distribution in the lungs and the high rate of absorption after this dose might be due to an increase in the lung surface exposed to this drug.
The effect of probenecid on the plasma levels of ampicillin after intratracheal administration is shown in Figure 3 . Plasma levels of ampicillin after an intratracheal injection of ampicillin and The bronchial slices were shown to be viable by the presence of active ciliary movement.
These results show no evidence of accumulation of ampicillin by human foetal bronchial slices.
DISCUSSION
Using plasma levels, the area under the plasma level-time curve and urinary excretion as measures of ampicillin absorption from the lungs, the rate of absorption of the drug was found to increase with the intratracheal dose. There is no evidence of rate limitation of absorption as would occur with saturation of an active transport mechanism for organic acids (Schanker, 1962) , and probenecid failed to reduce ampicillin absorption from the lungs. These findings, although preliminary, suggest that ampicillin is absorbed from the lungs by passive diffusion. Similar findings were obtained with acidic drugs such as paminohippurate in rats by Enna and Schanker (1970) . They found that organic acids were absorbed from the lungs by passive diffusion at rates related to their molecular size and lipid/ water partition coefficient.
From the present in vivo studies on pulmonary absorption of ampicillin it is not possible to distinguish between bronchial absorption and alveolar absorption, the results reflecting absorption from both surfaces. The results of the bronchial slice technique, however, provide no evidence of an active transport mechanism for ampicillin in the human bronchus. Similar findings have also been obtained with human bronchus using para-aminohippurate (Maddocks, 1973) . These results fail to confirm the suggestion of May and Delves (1965) that ampicillin might be actively secreted by the bronchial mucosa.
Thus it appears that the poor penetration of ampicillin into bronchial secretions is related to its physicochemical properties, particularly its strongly acidic group (pKa 2 52) and its poor solubility in lipids. This gives rise to the question whether the levels of ampicillin in bronchial secretions may be increased by some means. There are two approaches to this problem. First, the permeability of the blood-bronchial fluid barrier might be increased. Buergi, Regli, and Medici (1969) -i E 0 E E a.
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